$807 Million is the total value of HARVARD MANAGEMENT CO INC's 46 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 6.4% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
GOOGL | Alphabet Inccap stk cl a | $212,770,174 | -7.8% | 2,411,540 | 0.0% | 26.38% | -8.1% | |
SGMS | Light & Wonder Inc | $156,964,261 | +36.7% | 2,678,571 | 0.0% | 19.46% | +36.2% | |
FB | Meta Platforms Inccl a | $136,696,131 | -11.3% | 1,135,916 | 0.0% | 16.95% | -11.6% | |
Buy | Grab Holdings Limitedclass a ord | $41,977,472 | +71.6% | 13,036,482 | +40.2% | 5.20% | +71.0% | |
ABCL | Abcellera Biologics Inc | $41,584,612 | +2.4% | 4,105,095 | 0.0% | 5.16% | +2.1% | |
PCTTW | Purecycle Technologies Inc*w exp 03/17/202 | $16,887,629 | +595.3% | 714,285 | 0.0% | 2.09% | +593.4% | |
RVMD | Revolution Medicines Inc | $15,968,499 | +20.8% | 670,382 | 0.0% | 1.98% | +20.4% | |
RXRX | Recursion Pharmaceuticals Incl a | $11,636,348 | -27.5% | 1,509,254 | 0.0% | 1.44% | -27.8% | |
ASML | ASML Holding N V | $11,029,630 | +31.6% | 20,186 | 0.0% | 1.37% | +31.1% | |
PLRX | Pliant Therapeutics Inc | $10,870,786 | -7.5% | 562,379 | 0.0% | 1.35% | -7.8% | |
Meli Kaszek Pioneer Corpclass a ord | $9,970,000 | +1.0% | 1,000,000 | 0.0% | 1.24% | +0.7% | ||
NVDA | Nvidia Corporation | $9,699,020 | +20.4% | 66,368 | 0.0% | 1.20% | +20.0% | |
QRVO | Qorvo Inc | $9,487,198 | +14.1% | 104,669 | 0.0% | 1.18% | +13.7% | |
Sell | EQRX Inc | $9,479,283 | -63.6% | 3,853,367 | -26.8% | 1.18% | -63.7% | |
ADI | Analog Devices Inc | $8,950,789 | +17.7% | 54,568 | 0.0% | 1.11% | +17.3% | |
AMAT | Applied Matls Inc | $8,612,579 | +18.9% | 88,443 | 0.0% | 1.07% | +18.4% | |
RLAY | Relay Therapeutics Inc | $8,084,393 | -33.2% | 541,124 | 0.0% | 1.00% | -33.5% | |
LRCX | Lam Research Corp | $8,040,759 | +14.8% | 19,131 | 0.0% | 1.00% | +14.5% | |
TSM | Taiwan Semiconductor Mfg Ltdsponsored ads | $7,992,330 | +8.7% | 107,294 | 0.0% | 0.99% | +8.3% | |
AMD | Advanced Micro Devices Inc | $7,263,113 | +2.2% | 112,137 | 0.0% | 0.90% | +1.8% | |
TXG | 10X Genomics Inc | $6,783,051 | +28.0% | 186,143 | 0.0% | 0.84% | +27.4% | |
INTC | Intel Corp | $5,490,885 | +2.6% | 207,752 | 0.0% | 0.68% | +2.3% | |
MU | Micron Technology Inc | $5,373,950 | -0.2% | 107,522 | 0.0% | 0.67% | -0.6% | |
Tango Therapeutics Inc | $5,135,791 | +100.3% | 708,385 | 0.0% | 0.64% | +99.7% | ||
Rocket Lab Usa Inc | $3,770,000 | -7.4% | 1,000,000 | 0.0% | 0.47% | -7.7% | ||
Vigil Neuroscience Inc | $3,618,250 | +37.4% | 289,460 | 0.0% | 0.45% | +36.9% | ||
NRIX | Nurix Therapeutics Inc | $3,456,087 | -15.7% | 314,762 | 0.0% | 0.43% | -16.1% | |
KNTE | Kinnate Biopharma Inc | $3,037,806 | -49.0% | 498,001 | 0.0% | 0.38% | -49.1% | |
FULC | Fulcrum Therapeutics Inc | $2,989,998 | -10.0% | 410,714 | 0.0% | 0.37% | -10.2% | |
CFLT | Confluent Inc | $2,899,718 | -6.4% | 130,383 | 0.0% | 0.36% | -7.0% | |
PCT | Purecycle Technologies Inc | $2,057,141 | -89.8% | 2,498,170 | 0.0% | 0.26% | -89.8% | |
GBIO | Generation Bio Co | $2,005,691 | -26.0% | 510,354 | 0.0% | 0.25% | -26.1% | |
Nauticus Robotics Inc. | $1,870,000 | +3.6% | 500,000 | 0.0% | 0.23% | +3.1% | ||
PACB | Pacific Biosciences Calif Inc | $1,874,398 | +40.9% | 229,144 | 0.0% | 0.23% | +40.6% | |
SANA | Sana Biotechnology Inc | $1,851,559 | -34.2% | 468,749 | 0.0% | 0.23% | -34.3% | |
PRAX | Praxis Precision Medicines Inc | $1,852,870 | +4.9% | 778,517 | 0.0% | 0.23% | +4.5% | |
AFRM | Affirm Hldgs Inc | $1,678,325 | -48.5% | 173,560 | 0.0% | 0.21% | -48.6% | |
Tenaya Therapeutics Inc | $1,353,273 | -30.7% | 673,270 | 0.0% | 0.17% | -30.9% | ||
DYN | Dyne Therapeutics Inc | $1,243,051 | -8.7% | 107,252 | 0.0% | 0.15% | -8.9% | |
Xilio Therapeutics Inc | $1,119,199 | -7.6% | 416,059 | 0.0% | 0.14% | -7.9% | ||
MCRB | Seres Therapeutics Inc | $738,343 | -12.7% | 131,847 | 0.0% | 0.09% | -12.4% | |
Pardes Biosciences Inc | $676,000 | -8.6% | 400,000 | 0.0% | 0.08% | -8.7% | ||
DBTX | Decibel Therapeutics Inc | $674,036 | -40.8% | 328,798 | 0.0% | 0.08% | -40.8% | |
New | Disc Medicine Inc | $497,250 | – | 25,000 | +100.0% | 0.06% | – | |
Surrozen Inc | $481,145 | -71.2% | 826,852 | 0.0% | 0.06% | -71.2% | ||
MGTA | Magenta Therapeutics Inc | $131,381 | -72.0% | 332,610 | 0.0% | 0.02% | -72.4% | |
GMTX | Exit | Gemini Therapeutics Inc | $0 | – | -250,000 | -100.0% | -0.05% | – |
LAUR | Exit | Laureate Education Inc | $0 | – | -101,804 | -100.0% | -0.13% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-10
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ISHARES TR | 34 | Q3 2021 | 19.4% |
VANGUARD TAX-MANAGED INTL FD | 34 | Q3 2021 | 14.0% |
VANGUARD INTL EQUITY INDEX F | 34 | Q3 2021 | 12.2% |
SPDR GOLD TRUST | 34 | Q3 2021 | 8.7% |
ISHARES TR | 34 | Q3 2021 | 4.9% |
META PLATFORMS INC | 29 | Q3 2023 | 37.6% |
VANGUARD SPECIALIZED PORTFOL | 28 | Q1 2020 | 2.8% |
MAGENTA THERAPEUTICS INC | 21 | Q2 2023 | 1.4% |
ALPHABET INC | 19 | Q3 2023 | 30.4% |
ISHARES TR | 19 | Q3 2021 | 4.4% |
View HARVARD MANAGEMENT CO INC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
NuCana plc | February 12, 2021 | 1,678,239 | 3.3% |
ADURO BIOTECH, INC. | February 08, 2019 | 640,595 | 0.8% |
Fortress Transportation & Infrastructure Investors LLCSold out | July 08, 2016 | 0 | 0.0% |
Alpha Security Group CORP | February 13, 2009 | 436,300 | 5.8% |
BLOCKBUSTER INC | February 13, 2009 | 5,567,100 | 7.7% |
ChinaGrowth North Acquisition CORPSold out | February 13, 2009 | 0 | 0.0% |
ChinaGrowth South Acquisition CORPSold out | February 13, 2009 | 0 | 0.0% |
GENEVA ACQUISITION CORPSold out | February 13, 2009 | 0 | 0.0% |
Ideation Acquisition Corp. | February 13, 2009 | 310,200 | 2.5% |
MBF Healthcare Acquisition Corp. | February 13, 2009 | 1,220 | 0.0% |
View HARVARD MANAGEMENT CO INC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-09 |
13F-HR | 2023-11-09 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-10 |
13F-HR | 2022-11-10 |
13F-HR | 2022-08-12 |
13F-HR | 2022-05-13 |
13F-HR | 2022-02-11 |
13F-HR | 2021-11-12 |
View HARVARD MANAGEMENT CO INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.